C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2006
12/27/2006	EP1736545A2 Soluble zcytor 11 cytokine receptors
12/27/2006	EP1736540A1 Process for producing dipeptides
12/27/2006	EP1736163A1 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
12/27/2006	EP1735456A2 Polymeric compositions and related methods of use
12/27/2006	EP1735451A1 Mutated prokaryotic cells with high secretion-levels
12/27/2006	EP1735447A2 Cellulase fusion protein and heterologous cellulase fusion construct encoding the same
12/27/2006	EP1735340A2 Glycol linked fgf-21 compounds
12/27/2006	EP1735338A2 Anthrax antigens and methods of use
12/27/2006	EP1735337A1 Method of producing highly pure teicoplanin
12/27/2006	EP1438584A4 Target assisted iterative screening (tais) : a novel screening format for large molecular repertoires
12/27/2006	EP1368500B1 Method for preparative production of long nucleic acids by pcr
12/27/2006	EP1297147B1 Compositions for the diagnosis and treatment of herpes simplex virus infection
12/27/2006	EP1210449B1 Methods for the detection, analysis and isolation of nascent proteins
12/27/2006	EP1183362B1 Il-1 eta dna and polypeptides
12/27/2006	EP1163344B1 Hyphal growth in fungi
12/27/2006	EP1117798B1 Fungal transcriptional activator prtt from aspergillus niger, useful in methods for producing polypeptides
12/27/2006	EP0973804B1 Anti-vegf antibodies
12/27/2006	EP0749490B1 EXPRESSION OF $i(BACILLUS THURINGIENSIS CRY) PROTEINS IN PLANT PLASTIDS
12/27/2006	EP0638123B1 Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form
12/27/2006	CN1886504A Gene amplification method
12/27/2006	CN1886420A Self-assembling split-fluorescent protein systems
12/27/2006	CN1886042A Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs
12/27/2006	CN1884574A Angiotensin converting enzyme inhibitory peptide production method
12/27/2006	CN1884573A Antibacterial peptide-x fermentation process
12/27/2006	CN1884572A Direct enzyme hydrolysis method for preparing rapeseed peptide using rapeseed cake
12/27/2006	CN1884527A Method for preparing protein using endogenetic angiogenesis inhibitive factor Arresten gene
12/27/2006	CN1884516A Design and fermented production of recombinant peptide for reducing blood pressure
12/27/2006	CN1884505A Tumour related protein kinase RX17 and its uses
12/27/2006	CN1883536A Orally administered cervus and cucumis polypeptide composition and preparation method thereof
12/27/2006	CN1292075C Preparation method of water soluble undenatured natural collagen
12/27/2006	CN1292074C Separation of soybean polypeptide, peptone and amino acid by biological fermentation
12/27/2006	CN1292068C Enhanced expression of proteolytic enzymes in koji mold
12/27/2006	CA2549275A1 Neoplasia-specific splice variants and methods
12/26/2006	US7153951 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives
12/26/2006	US7153950 For diagnosis of/drugs for inflammatory bowel disease/asthma/ diabetes/arthritis/cirrhosis/skin disorders
12/26/2006	US7153949 Nucleic acid encoding poly-zinc finger proteins with improved linkers
12/26/2006	US7153947 Ixodes salivary anticomplement protein
12/26/2006	US7153940 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
12/26/2006	US7153939 PRO354 antibodies
12/26/2006	US7153936 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity
12/26/2006	US7153934 T cell costimulatory polypeptides containing alternative domains
12/26/2006	US7153932 Immunotoxins comprising ribosome-inactivating proteins
12/26/2006	US7153827 Produced by recombinant techniques; stimulating angiogenesis for wound healing and for vascular tissue repair
12/26/2006	US7153701 Mixing the Fab' antibody having a uniform isoelectric point with analytical sample containing antigen to obtain a mixture comprising immune complex, separating the mixture by performing electrophoresis in a carrier, irradiating an excitation light which excites fluorescent dye, detecting fluorescece
12/26/2006	US7153680 Recombinant watermelon (Citrullus lanatus) hydroperoxide lyase and uses thereof
12/26/2006	US7153678 Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof
12/26/2006	US7153677 Isolated, recombinantly produced, enzymatically active hyaluronan synthase; a single protein that is a dual-action catalyst that utilizes UDP-GlcA and UDP-GlcNAc to synthesize hyaluronic acid
12/26/2006	US7153676 purified protein; nucleic acid sequences encoding the transacylases and fragments of the transacylases can be cloned, using standard molecular biology techniques, into vectors to transform host cells
12/26/2006	US7153674 Comprises sucrose fructosyltransferases (SST) for fermenting water-soluble, biodegradable polysaccharides for use as detergents, suspension agents, artificial sweeteners and food additives
12/26/2006	US7153670 Isolated nucleic acid molecule of nucleotides that encode full-length WF-HABP, Hyaluronan-binding protein family
12/26/2006	US7153669 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
12/26/2006	US7153668 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular disoders
12/26/2006	US7153667 Discrete acyltransferases associated with type I polyketide synthases and methods of use
12/26/2006	US7153664 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory disorders
12/26/2006	US7153663 Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from Comamonas testosteroni 5-MGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and acids
12/26/2006	US7153662 Inflammation-specific peptides and the uses thereof
12/26/2006	US7153659 Bioassay for measuring the proliferation of T-cells in Human papiloma virus
12/26/2006	US7153507 A human monoclonal antibody specifically binds to human IL-15 and to inhibit IL-15-induced proinflammatory effects; tumor necrosis factor; antiinflammatory, -arthritic, -carcinogenic, proliferative agents; rheumatic diseases; transplants
12/26/2006	US7153499 Promoting differentiation and maturation of immature dendritic cells in a regional lymph node (especially by administering a natural cytokine mixture parilymphatically) so that the cells deliver T-cell antigen to effect immunization
12/21/2006	WO2006135096A1 Method of site specifically introducing tyrosine analogue into protein
12/21/2006	WO2006134917A1 Method for production of antibody
12/21/2006	WO2006134752A1 Soybean peptide composition
12/21/2006	WO2006133566A1 NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF
12/21/2006	WO2006133560A1 Psp94 diagnostic reagents and assays
12/21/2006	WO2006116001A3 Antibodies for the treatment of cancers
12/21/2006	WO2006089133A3 Anti-cd19 antibodies and uses in oncology
12/21/2006	WO2006081207A3 Process for genetic engineering of cell lines
12/21/2006	WO2005100584A3 Production of galactosylated glycoproteins in lower eukaryotes
12/21/2006	WO2005086794A3 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
12/21/2006	WO2004101750A3 IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
12/21/2006	WO2004020578A3 Glycosylation modified il-20
12/21/2006	US20060288450 Plant N-acylethanolamine binding proteins
12/21/2006	US20060288437 Zinc finger-based drug-dependent gene regulation system
12/21/2006	US20060288434 Inhibiting angiogenesis in a mammal by administering an antibody which specifically binds to EphriniB2 or EphB4; cardiovascular disorders
12/21/2006	US20060288432 Identification of a jak2 mutation in polycythemia vera
12/21/2006	US20060288431 Marker for undifferentiated state of cell and composition and method for separation and preparation of stem cells
12/21/2006	US20060287513 Compositions and methods for the therapy and diagnosis of breast cancer
12/21/2006	US20060287509 isolated nucleic acid encoding a human antibody that specifically binds to C-ERBB-2 protein product of HER2/NEU oncogene; for diagnosis of cancer/tumors which over express this gene; for immunotoxins and other antitumor/anticarcinogenic agents; less immunogenic
12/21/2006	US20060287508 Methods for stabilizing proteins
12/21/2006	US20060287504 Universal procedure for refolding recombinant proteins
12/21/2006	US20060287503 Analyzing fusion protein expression; biological screening
12/21/2006	US20060287502 C3b/C4b complement receptor-like molecules and uses thereof
12/21/2006	US20060287501 Soluble truncated polypeptides of the nogo-a protein
12/21/2006	US20060287432 Peptide purification by means of metal ion affinity chromatography
12/21/2006	US20060287252 Substances k01-0509 and process for producing the same
12/21/2006	US20060287236 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
12/21/2006	US20060287230 Compositions which can be used for regulating the activity of parkin
12/21/2006	US20060287228 Expression of active human factor IX in mammary tissue of transgenic animals
12/21/2006	US20060287223 Remodeling and glycoconjugation of peptides
12/21/2006	US20060286656 Characterization of the I-SpomI endonuclease from fission yeast
12/21/2006	US20060286641 Interferon-alpha/beta binding fusion proteins and therapeutic uses thereof
12/21/2006	US20060286640 Process for production of polypeptides
12/21/2006	US20060286639 Complementary DNAs encoding proteins with signal peptides
12/21/2006	US20060286638 Cell lines
12/21/2006	US20060286637 Using transgenic yeast as bioreactor for generation of sialylated glycoprotein
12/21/2006	US20060286636 VEGF variants
12/21/2006	US20060286635 Albumin fusion proteins
12/21/2006	US20060286634 Vector
12/21/2006	US20060286633 Methods for production of proteins
12/21/2006	US20060286632 Genetic engineered apolipoproteins has potent antioxidant activity on phospholipid surfaces; cardiovascular disorders, antiischemic agents, bone disorders, antiinflammatory agents

1 ... 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 ... 1125